Safety and Tolerability in Healthy Volunteers
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Annexon BiosciencesANX009
NeuralyNLY01
Annexon BiosciencesANX005
Clinical Trials (3)
A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)
Start: Oct 2020Est. completion: Jun 2021
Phase 1Completed
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
Start: Sep 2018Est. completion: Jul 2019
Phase 1Completed
Single Dose Study of ANX005 in Healthy Volunteers
Start: Dec 2016Est. completion: Jun 2018
Phase 1Terminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space